Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings.
The state’s Supreme Court restored the judgment, agreeing that John Farmer, Jr., MD, was branded with a “proverbial scarlet letter” after the complaint, which spiraled out of control and damaged his career.
A phishing attack on Xsolis, a Tennessee-based company whose list of clients includes hospitals and healthcare payers, was confirmed to have exposed sensitive medical information, including details on treatments that patients received.
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.
Care teams have a lot to consider when choosing the right treatment for patients with severe aortic stenosis. Two cardiologists and a veteran cardiothoracic surgeon are taking part in a new webinar focused on that very topic.
The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics.
Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings.
The state’s Supreme Court restored the judgment, agreeing that John Farmer, Jr., MD, was branded with a “proverbial scarlet letter” after the complaint, which spiraled out of control and damaged his career.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/stack_views/public/2024-09/istock-1209664264.jpg.webp?itok=MzQCOefT)
